ENZN.D logo

Enzon Pharmaceuticals, Inc. Stock Price

OTCPK:ENZN.D Community·US$3.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

ENZN.D Share Price Performance

US$5.55
-4.84 (-46.56%)
US$5.55
-4.84 (-46.56%)
Price US$5.55

ENZN.D Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

Enzon Pharmaceuticals, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$5.5m

Other Expenses

-US$5.5m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-7.46
0%
0%
0%
View Full Analysis

About ENZN.D

Founded
1981
Employees
n/a
CEO
Richard Feinstein
WebsiteView website
enzon.com

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

Recent ENZN.D News & Updates

Recent updates

No updates